Par Health USA, LLC - NDC products
NDC labeler, manufacturer of drugs and pharmaceuticals
Products with assigned NDCs are displayed. Select the NDC to see product information. Select the Trade Name to see similar products.
Hide deleted NDCs:
| NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
|---|---|---|---|---|
| 42023-0101 | Adrenalin | JHP Pharmaceuticals LLC | Yes | No later than 2013-12-31 |
| 42023-0122 | Adrenalin | JHP Pharmaceuticals LLC | Yes | No later than 2013-12-31 |
| 42023-0159 | Adrenalin | ENDO USA, Inc. | No | |
| 42023-0168 | Adrenalin | Par Health USA, LLC | No | |
| 42023-0273 | Adrenalin (epinephrine in sodium chloride) | Par Health USA, LLC | No | |
| 42023-0315 | Adrenalin (epinephrine in sodium chloride) | Par Health USA, LLC | No | |
| 42023-0434 | Adrenalin (epinephrine in sodium chloride) | Par Health USA, LLC | No | |
| 42023-0500 | Adrenalin (epinephrine in sodium chloride) | Par Health USA, LLC | No | |
| 42023-0721 | Adrenalin (epinephrine in sodium chloride) | Par Health USA, LLC | No | |
| 42023-0104 | Aplisol | ENDO USA, Inc. | No | |
| 42023-0182 | Argatroban | Par Health USA, LLC | No | |
| 42023-0622 | Bivalirudin | Endo USA, Inc. | No | |
| 42023-0105 | Brevital Sodium | Par Health USA, LLC | No | |
| 42023-0106 | Brevital Sodium | Par Pharmaceutical, Inc. | Yes | 2021-01-31 |
| 42023-0148 | Brevital Sodium | JHP Pharmaceuticals LLC | Yes | No later than 2014-12-22 |
| 42023-0179 | Buprenorphine Hydrochloride | Endo USA, Inc. | No | |
| 42023-0205 | Calcitonin Salmon | Par Health USA, LLC | No | |
| 42023-0131 | Colistimethate | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
| 42023-0107 | Coly-Mycin M | Endo USA, Inc. | No | |
| 42023-0108 | Coly-Mycin S | Par Pharmaceutical, Inc. | Yes | 2017-06-18 |
| 42023-0196 | Corphedra | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
| 42023-0233 | Corphedra | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
| 42023-0109 | Cortisporin-TC | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
| 42023-0123 | Dantrium | Par Health USA, LLC | No | |
| 42023-0124 | Dantrium | Endo USA, Inc. | No | |
| 42023-0125 | Dantrium | Par Pharmaceutical, Inc. | Yes | 2022-02-28 |
| 42023-0126 | Dantrium | Par Pharmaceutical Inc. | Yes | No later than 2017-06-30 |
| 42023-0144 | dantrolene sodium | Par Pharmaceutical, Inc. | Yes | 2020-05-31 |
| 42023-0145 | dantrolene sodium | JHP Pharmaceuticals, LLC | Yes | No later than 2017-12-29 |
| 42023-0295 | Daptomycin | Par Health USA, LLC | No | |
| 42023-0110 | Delestrogen | ENDO USA, Inc. | No | |
| 42023-0111 | Delestrogen | ENDO USA, Inc. | No | |
| 42023-0112 | Delestrogen | ENDO USA, Inc. | Yes | 2024-09-30 |
| 42023-0146 | Dexmedetomidine Hydrochloride | Par Health USA, LLC | No | |
| 42023-0186 | Dexmedetomidine Hydrochloride | Par Health USA, LLC | No | |
| 42023-0187 | Dexmedetomidine Hydrochloride | Par Health USA, LLC | No | |
| 42023-0244 | DOXYCYCLINE | Endo USA, Inc. | No | |
| 42023-0216 | Ephedrine Sulfate | Par Health USA, LLC | No | |
| 42023-0243 | EPHEDRINE SULFATE | ENDO USA, Inc. | No | |
| 42023-0253 | EPHEDRINE SULFATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-06-26 |
| 42023-0221 | ERTAPENEM | ENDO USA, Inc. | No | |
| 42023-0134 | Estradiol Valerate | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
| 42023-0135 | Estradiol Valerate | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
| 42023-0136 | Estradiol Valerate | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
| 42023-0157 | ETHACRYNATE SODIUM | Par Health USA, LLC | No | |
| 42023-0169 | Etomidate | Par Pharmaceutical, Inc. | Yes | No later than 2015-09-28 |
| 42023-0170 | Etomidate | Par Pharmaceutical, Inc. | Yes | No later than 2015-09-28 |
| 42023-0129 | Fluphenazine Decanoate | Endo USA, Inc. | No | |
| 42023-0173 | Ganciclovir | Endo USA, Inc. | No | |
| 42023-0113 | Ketalar | Par Health USA, LLC | No | |
| 42023-0114 | Ketalar | Par Health USA, LLC | No | |
| 42023-0115 | Ketalar | Par Health USA, LLC | No | |
| 42023-0137 | ketamine hydrochloride | Par Pharmaceutical Inc. | Yes | 2018-05-06 |
| 42023-0138 | ketamine hydrochloride | Par Pharmaceutical Inc. | Yes | 2018-04-29 |
| 42023-0139 | ketamine hydrochloride | Par Pharmaceutical Inc. | Yes | 2018-05-12 |
| 42023-0161 | Levothyroxine Sodium | Par Pharmaceutical Companies, Inc. | Yes | No later than 2019-12-28 |
| 42023-0201 | Levothyroxine Sodium | ENDO USA, Inc. | No | |
| 42023-0202 | Levothyroxine Sodium | ENDO USA, Inc. | No | |
| 42023-0203 | Levothyroxine Sodium | ENDO USA, Inc. | No | |
| 42023-0149 | Melphalan Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2020-04-01 |
| 42023-0191 | Meropenem | Par Pharmaceutical, Inc. | Yes | 2018-09-30 |
| 42023-0192 | Meropenem | Par Pharmaceutical, Inc. | Yes | 2018-05-31 |
| 42023-0238 | METHYLPREDNISOLONE ACETATE | Endo USA, Inc. | No | |
| 42023-0239 | METHYLPREDNISOLONE ACETATE | Endo USA, Inc. | No | |
| 42023-0240 | Methylprednisolone Acetate | Endo USA, Inc. | No | |
| 42023-0229 | Micafungin | Par Health USA, LLC | No | |
| 42023-0230 | Micafungin | Par Health USA, LLC | No | |
| 42023-0172 | Mycophenolate Mofetil | Endo USA, Inc. | No | |
| 42023-0224 | Naloxone Hydrochloride | Par Health USA, LLC | No | |
| 42023-0188 | NEOSTIGMINE METHYLSULFATE | Par Health USA, LLC | No | |
| 42023-0189 | NEOSTIGMINE METHYLSULFATE | Par Health USA, LLC | No | |
| 42023-0245 | NOREPINEPHRINE BITARTRATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-03-26 |
| 42023-0246 | NOREPINEPHRINE BITARTRATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-03-26 |
| 42023-0247 | NOREPINEPHRINE BITARTRATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-03-26 |
| 42023-0140 | Oxytocin | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
| 42023-0141 | Oxytocin | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
| 42023-0213 | Phenylephrine hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
| 42023-0214 | Phenylephrine hydrochloride | Par Health USA, LLC | No | |
| 42023-0215 | Phenylephrine hydrochloride | Par Health USA, LLC | No | |
| 42023-0116 | Pitocin | Par Health USA, LLC | No | |
| 42023-0130 | Pitocin | Par Health USA, LLC | No | |
| 42023-0117 | Pitressin | Par Pharmaceutical, Inc. | Yes | 2016-06-30 |
| 42023-0195 | Posaconazole | Endo USA, Inc. | No | |
| 42023-0269 | PREVDUO | Endo USA | No | |
| 42023-0121 | sumatriptan succinate | JHP Pharmaceuticals LLC | Yes | No later than 2019-12-28 |
| 42023-0118 | Tigan | Par Pharmaceutical, Inc. | Yes | 2022-03-31 |
| 42023-0119 | Tigan | Par Health USA, LLC | No | |
| 42023-0206 | Treprostinil | Endo USA, Inc. | Yes | 2025-03-31 |
| 42023-0207 | Treprostinil | Endo USA, Inc. | Yes | No later than 2025-03-24 |
| 42023-0208 | Treprostinil | Endo USA, Inc. | Yes | No later than 2025-03-24 |
| 42023-0209 | Treprostinil | Endo USA, Inc. | Yes | No later than 2025-03-24 |
| 42023-0142 | Trimethobenzamide Hydrochloride | JHP Pharmaceuticals, LLC | Yes | No later than 2015-09-28 |
| 42023-0143 | Trimethobenzamide Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2016-12-31 |
| 42023-0120 | Triostat | Par Pharmaceutical, Inc. | Yes | No later than 2023-03-29 |
| 42023-0164 | Vasostrict | Par Health USA, LLC | No | |
| 42023-0190 | Vasostrict | Par Health USA, LLC | No | |
| 42023-0219 | Vasostrict | Par Health USA, LLC | No | |
| 42023-0220 | Vasostrict | Par Pharmaceutical, Inc. | Yes | No later than 2023-12-19 |
| 42023-0237 | Vasostrict | Par Health USA, LLC | No | |
| 42023-0151 | Zoledronic Acid | Par Pharmaceutical Companies, Inc. | Yes | No later than 2019-12-28 |
| 42023-0163 | Zoledronic Acid | Par Pharmaceutical Companies, Inc. | Yes | No later than 2019-12-28 |
| 42023-0167 | Zoledronic Acid | JHP Pharmaceuticals, LLC. | Yes | No later than 2019-12-28 |
Thank you for choosing Find-A-Code, please Sign In to remove ads.

Quick, Current, Complete - www.findacode.com